Clinical trial · Observational
Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials
NCT07456436CI-TRIAL-00122601active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study assesses patient awareness and understanding of cancer clinical trials.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic and Lymphatic System Neoplasm | Hematopoietic and Lymphatic System Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Malignant Solid Neoplasm | Malignant Solid Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non-Interventional Study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational
- description
- Patients review educational materials and complete surveys on study.
- interventionNames
- Other: Non-Interventional Study
Primary outcomes (1)
- measure
- Change in Baseline Survey Score
- timeFrame
- Through study completion, up to 1 year
- description
- The survey is a validated instrument (CHEKS\*) evaluated patients' knowledge and beliefs about cancer clinical trials (CCTs) before and after exposure to educational stimuli (written and video) detailing the purpose and characteristics of CCTs. The survey scores knowledge and beliefs about CCTs on a 100-point scale.The survey is collected before and after education materials are provided. The change in survey score will be analyzed. A paired t-test will be used to examine changes in CCT knowledge and Chi-Square tests of association to determine whether CCT knowledge and beliefs are associated with sociodemographic variables. \*Chung A, Donley T, Hays RD, et al. Development and evaluation of the Clinical Trial HEalth Knowledge and Beliefs Scale (CHEKS). Int J Environ Res Public Health. 2022;19(14):8660. doi:10.3390/ijerph19148660
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Eligible patient participants will be: * Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported * Have been diagnosed any cancer type Exclusion Criteria: * Participants (patients) will be excluded if they: * Are unable to give informed consent * Are unable to speak English or Spanish
References
Publications (0)
Data not yet available
No reference posted for this study.